Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT00031408 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Consent for Use of Stored Patient Specimens for Future Testing

StatusActive, Not Recruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗

Amendment history

  1. Minor

    Trial status: Recruiting to Active, Not Recruiting

    Enrollment target: estimated 30000 to confirmed 17444; Site details revised at 63 of 63 sites

    Study Status, Study Design, Contacts/Locationsv44

  2. Minor

    Site contacts updated at 12 of 63 sites

    Study Status, Contacts/Locationsv43

  3. Notable

    Primary and study completion dates: Dec 31, 2023 to Dec 31, 2027

    Study Statusv42

  4. Notable

    Trial status: Active, Not Recruiting to Recruiting

    Site details revised at 63 of 63 sites

    Study Status, Contacts/Locationsv41

  5. Minor

    Start date: Mar 2002 to Feb 13, 2002

    Study Statusv40

Show 38 earlier versions

  1. Minor

    Trial status: Recruiting to Active, Not Recruiting

    Site details revised at 63 of 63 sites

    Study Status, Contacts/Locationsv39

  2. Minor

    3 amendments

    3 re-verifications since 2018-10-16, no change to tracked fields

    v36-v38

  3. Notable

    Primary and study completion dates: Dec 2018 to Dec 31, 2023

    Study Statusv35

  4. Minor

    Study sites: 68 to 63

    Study Status, Contacts/Locationsv34

  5. Notable

    Primary and study completion dates: Dec 2016 to Dec 2018

    Study Statusv33

  6. Notable

    Enrollment target: 20000 to 30000

    Study Status, Study Designv32

  7. Minor

    3 amendments

    3 re-verifications since 2014-07-08, no change to tracked fields

    v29-v31

  8. Notable

    Primary completion date: Apr 2005 to Dec 2016

    Completion date: Dec 2012 to Dec 2016

    Study Statusv28

  9. Minor

    2 amendments

    2 re-verifications since 2012-01-19, no change to tracked fields

    v26-v27

  10. Minor

    Completion date: Dec 2012

    Study Statusv25

  11. Notable

    Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID) to Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections

    Collaborators expanded, about 8 words

    Show what changed: Collaborators
    National Institute of Allergy and Infectious Diseases (NIAID)

    Study Identification, Study Status, Sponsor/Collaboratorsv24

  12. Minor

    Study sites: 67 to 68

    Study Status, Contacts/Locationsv23

  13. Minor

    Study sites: 66 to 67

    Study Status, Contacts/Locationsv22

  14. Notable

    Trial status: Active, Not Recruiting to Recruiting

    Study sites: 65 to 66

    Study Status, Contacts/Locationsv21

  15. Minor

    Trial status: Recruiting to Active, Not Recruiting

    Primary completion date: Apr 2005; Start date: Mar 2002; Site details revised at 65 of 65 sites

    Study Status, Sponsor/Collaborators, Study Design, Eligibility, Contacts/Locationsv20

  16. Minor

    Study Status

    Re-verified, no change to tracked fields

    v19

  17. Minor

    Site details revised at 2 of 65 sites

    Study Status, Contacts/Locationsv18

  18. Minor

    Site details revised at 2 of 65 sites

    Study Status, Contacts/Locationsv17

  19. Minor

    Study sites: 64 to 65

    Study Status, Study Design, Contacts/Locationsv16

  20. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv15

  21. Notable

    Enrollment target: 50000 to 20000

    Study Status, Study Designv14

  22. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv13

  23. Minor

    Site details revised at 1 of 64 sites

    Study Status, Study Design, Contacts/Locationsv12

  24. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv11

  25. Minor

    Site details revised at 2 of 64 sites

    Study Status, Contacts/Locationsv10

  26. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv9

  27. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv8

  28. Minor

    Site details revised at 1 of 64 sites

    Study Status, Eligibility, Contacts/Locationsv7

  29. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv6

  30. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv5

  31. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv4

  32. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv3

  33. Minor

    Site details revised at 1 of 64 sites

    Study Status, Contacts/Locationsv2

  1. Minor

    Study First Submitted

  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
The purpose of this study is to obtain informed consent to use stored human biological materials (HBM) (e.g., blood and other tissues) for future studies that may include genetic testing.
Trial Details
NCT Number NCT00031408
Lead Sponsor Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV Infections
Enrollment 17,444 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov